| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,154 |
4,675 |
$419K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,662 |
4,201 |
$256K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
976 |
932 |
$74K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
761 |
679 |
$52K |
| 99215 |
Prolong outpt/office vis |
435 |
388 |
$45K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
457 |
432 |
$33K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
384 |
377 |
$32K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,651 |
773 |
$20K |
| 99401 |
|
730 |
708 |
$15K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
515 |
493 |
$15K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
261 |
251 |
$11K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
137 |
131 |
$10K |
| 90670 |
|
431 |
403 |
$10K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
1,232 |
1,093 |
$9K |
| 92552 |
|
330 |
305 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
644 |
573 |
$8K |
| 90688 |
|
678 |
655 |
$8K |
| 90686 |
|
638 |
598 |
$7K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
809 |
720 |
$6K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
191 |
185 |
$6K |
| 96127 |
|
1,280 |
1,142 |
$6K |
| 90700 |
|
449 |
419 |
$5K |
| 99177 |
|
1,017 |
949 |
$4K |
| 90648 |
|
341 |
318 |
$3K |
| 90651 |
|
102 |
87 |
$3K |
| 90713 |
|
218 |
210 |
$3K |
| 99000 |
|
1,140 |
1,030 |
$2K |
| 0002A |
|
59 |
58 |
$2K |
| 90656 |
|
146 |
143 |
$2K |
| 90680 |
|
118 |
104 |
$2K |
| 99173 |
|
658 |
632 |
$2K |
| 0001A |
|
37 |
37 |
$2K |
| 3008F |
|
1,098 |
1,063 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
27 |
26 |
$874.90 |
| 90716 |
|
27 |
27 |
$864.13 |
| 90685 |
|
74 |
70 |
$853.35 |
| 92551 |
|
82 |
81 |
$744.73 |
| 81002 |
|
273 |
258 |
$741.64 |
| 90633 |
|
56 |
51 |
$668.65 |
| 85018 |
|
256 |
244 |
$598.40 |
| 90744 |
|
41 |
41 |
$546.41 |
| 90707 |
|
24 |
24 |
$494.79 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
123 |
110 |
$381.56 |
| 96160 |
|
161 |
156 |
$346.63 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
15 |
12 |
$191.58 |
| 96161 |
|
104 |
92 |
$170.32 |
| 90734 |
|
17 |
16 |
$168.00 |
| 90698 |
|
13 |
13 |
$147.75 |
| 36416 |
|
298 |
282 |
$115.25 |
| 90671 |
|
18 |
12 |
$107.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
46 |
46 |
$72.09 |
| 90461 |
|
28 |
27 |
$20.40 |
| 99070 |
|
23 |
23 |
$5.00 |
| 91300 |
|
110 |
98 |
$1.08 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
14 |
12 |
$0.44 |
| 3210F |
|
56 |
56 |
$0.00 |